Cargando…
Substance use identification and follow-up rates among commercial and Medicare health insurance members in primary care and other settings
BACKGROUND: The objective of this study was to investigate factors associated with substance use disorder identification and follow-up rates among samples of members of a private health insurance plan. METHODS: In an observational study, samples of claims data for 2017 for Commercial and Medicare me...
Autores principales: | Baker, John G., Doxbeck, David R., Washington, Melanie E., Horton, Angela, Dunning, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604972/ https://www.ncbi.nlm.nih.gov/pubmed/33131488 http://dx.doi.org/10.1186/s12875-020-01286-8 |
Ejemplares similares
-
Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022) -
915 Is a hospital's surgical site infection rate among Medicare-insured patients a good indicator of outcome for commercially-insured patients?
por: Calderwood, Michael S., et al.
Publicado: (2014) -
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020) -
Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021) -
Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)